Incretin-Based Drugs and the Risk of Acute Pancreatitis
These may include but are not limited to: Constipation Diarrhea Nausea Vomiting In some cases, GLP-1 medications may cause serious reactions, such as pancreatitis or vision changes
All present issues
Accessed June 4 2025
Glucagon-like peptide-1 receptor (GLP-1) agonists are an effective treatment for controlling blood glucose levels in people with type 2 diabetes, particularly those who do not respond, or stop responding to, first-line treatments, such as There are many versions of GLP-1 drugs, including: liraglutide(Victoza), which people inject daily semaglutide (Rybelsus), an oral tablet which people take once daily dulaglutide(Trulicity), which people inject once a week semaglutide (Ozempic/ Wegovy), which people inject once a week exenatide(Bydureon), which people inject once a week
This means that these supplements can enter the market without undergoing the same rigorous safety and effectiveness testing required for medications